Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Jul 27, 2024; 16(7): 2183-2193
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2183
Figure 1
Figure 1 Comparison of immune function between the two groups after treatment. A: CD3+ T lymphocytes; B: CD4+ T lymphocytes; C: CD8+ T lymphocytes; D: CD4+/CD8+ T lymphocyte ratio; E: NK cells; F: IgG; G: IgA; H: IgM. CD3+: Cluster of differentiation 3; CD4+: Cluster of differentiation 4; CD8+: Cluster of differentiation 8; IgA: Immunoglobulin A; IgG: Immunoglobulin G; IgM: Immunoglobulin M; NK: Natural killer.
Figure 2
Figure 2 Comparison of levels of inflammatory mediators between the two groups after treatment. A: Interleukin (IL)-6; B: IL-10; C: Tumor necrosis factor-alpha; D: C-reactive protein. CRP: C-reactive protein; IL-6: Interleukin-6; IL-10: Interleukin-10; TNF-α: Tumor necrosis factor-alpha.